Research priorities of the European Society of Clinical Pharmacy (ESCP): a questionnaire-based study
Status Publisher Language English Country Netherlands Media print-electronic
Document type Journal Article
PubMed
40540123
DOI
10.1007/s11096-025-01954-8
PII: 10.1007/s11096-025-01954-8
Knihovny.cz E-resources
- Keywords
- Barriers, Clinical pharmacist, European Society of Clinical Pharmacy, Research priorities,
- Publication type
- Journal Article MeSH
INTRODUCTION: It is important for health professional societies to involve members in defining their roles and future activities including research priorities. AIM: This study aimed to identify members' views on the areas of research that European Society of Clinical Pharmacy (ESCP) should prioritise in delivering research support, research projects and education. METHOD: An online questionnaire was initially developed by the ESCP Research Committee and reviewed by the research team. It included structured and open-ended items related to respondents' demographics, research experience, views on future research priorities, topics that ESCP should prioritise, and barriers to research involvement. After testing face and content validity, the questionnaire was sent to all ESCP members (N = 417). Descriptive statistics and summative content analysis were used. RESULTS: Eighty-two responses were received (response rate: 19.7%). Research on real-world processes that facilitate the implementation of clinical pharmacy services into every-day practice was the priority for most respondents (n = 77, 93.9%). Respondents believed that ESCP should focus on research support for implementation science (n = 52, 63.4%) and methods to analyse clinical judgement and decision-making (n = 48, 58.5%). The perceived barriers to developing high-quality research in clinical pharmacy were reported as a lack of knowledge, skills and training, limited funding opportunities and insufficient time. CONCLUSION: Research topics identified will help to inform ESCP and its committees on the priorities for research activities of the society in the near future, as well as other collaborating professional organisations of the current priority research objectives of ESCP in the international context.
Cantonal Hospital Aarau Aarau Switzerland
Clinical Pharmacy Department Faculty of Pharmacy Marmara University Istanbul Türkiye
Department of Clinical Pharmacy Innsbruck University Innsbruck Austria
Department of Pharmacy Faculty of Medicine and Surgery University of Malta Msida Malta
Department of Pharmacy Pharmacology and Toxicology Radboudumc Nijmegen The Netherlands
Pharmacy Programme Oman College of Health Sciences Muscat Oman
Robert Gordon University Aberdeen UK
Royal College of Surgeons Dublin Ireland
School of Pharmacy and Pharmaceutical Sciences Trinity College Dublin Dublin Ireland
See more in PubMed
Dreischulte T, van den Bemt B, Steurbaut S, et al. European Society of Clinical Pharmacy definition of the term clinical pharmacy and its relationship to pharmaceutical care: a position paper. Int J Clin Pharm. 2022;44(4):837–42. PubMed DOI PMC
Paudyal V, Fialová D, Henman MC, et al. Pharmacists’ involvement in COVID-19 vaccination across Europe: a situational analysis of current practice and policy. Int J Clin Pharm. 2021;43(4):1139–48. PubMed DOI PMC
Paudyal V, Cadogan C, Fialová D, et al. Provision of clinical pharmacy services during the COVID-19 pandemic: experiences of pharmacists from 16 European countries. Res Social Adm Pharm. 2021;17(8):1507–17. PubMed DOI
Patterson SM, Cadogan C, Barry HE, et al. Cross-sectional questionnaire study of the experiences of community pharmacists in Northern Ireland during the early phases of the COVID-19 pandemic: preparation, experience and response. BMJ Open. 2022;12(9):e064545. PubMed DOI
Jebara T, Cunningham S, MacLure K, et al. Stakeholders’ views and experiences of pharmacist prescribing: a systematic review. Br J Clin Pharmacol. 2018;84(9):1883–905. PubMed DOI PMC
Weeks G, George J, Maclure K, et al. Non-medical prescribing versus medical prescribing for acute and chronic disease management in primary and secondary care. Cochrane Database Syst Rev. 2016;11(11):CD011227. PubMed
European Society of Clinical Pharmacy. Clinical Pharmacy, Vision and Mission. https://escpweb.org/about-us/vision-mission-values/ . Accessed 19 Jan 2025.
Fernandez-Llimos F, Desselle S, Stewart D, et al. Improving the quality of publications in and advancing the paradigms of clinical and social pharmacy practice research: the Granada Statements. Int J Clin Pharm. 2023;45(2):285–92. PubMed DOI PMC
Alves da Costa F, Fernandez-Llimos F, Desselle S, et al. The International Collaboration of Pharmacy Journal Editors (ICPJE) formally constituted to foster quality around clinical and social pharmacy practice research publications. Int J Clin Pharm. 2025;47(1):4–7. PubMed DOI
Stewart D, Pouls B, da Costa FA. Editorial. Int J Clin Pharm. 2021;43(3):439–40. PubMed DOI
Thomas A, Forsyth P, Griffiths C, et al. Implementation and evaluation of pharmacist-led heart failure diagnostic and guideline directed medication therapies clinic. Int J Clin Pharm. 2024;46(6):1247–55. PubMed DOI
Tait LA, Cassidy N, Jamieson D, et al. Medication supply at hospital discharge via community pharmacy: a quality improvement study. Int J Clin Pharm. 2023;45(6):1309–16. PubMed DOI
Hogg A, Scott M, Fleming G, et al. The Medicines Optimisation Innovation Centre: a dedicated centre driving innovation in medicines optimisation-impact and sustainability. Int J Clin Pharm. 2024;46(5):1001–9. PubMed DOI PMC
Stewart D, Paudyal V, Cadogan C, et al. A survey of the European Society of Clinical Pharmacy members’ research involvement, and associated enablers and barriers. Int J Clin Pharm. 2020;42(4):1073–87. PubMed DOI PMC
Dooley M, Dowling H, Eaton V, et al. Identifying priorities for the pharmacy profession: the SHPA 2014 Future Summit. J Pharm Pract Res. 2015;45(1):76–80. DOI
Nyanchoka L, Tudur-Smith C, Thu VN, et al. A scoping review describes methods used to identify, prioritize and display gaps in health research. J Clin Epidemiol. 2019;109:99–110. PubMed DOI
Ambler S, Sheldrake L. Pharmacy practice research: challenges and opportunities. Primary Health Care Res Dev. 2009;10(1):4–6. DOI
Eysenbach G. Improving the quality of Web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES). J Med Internet Res. 2004;6(3):e34. PubMed DOI PMC
Rogers EM. Diffusion of innovations. New York: Free Press; 2003.
Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277–88. PubMed DOI
Lee R, Dahri K, Lau TTY, Shalansky S. Perceptions of hospital pharmacists concerning clinical research: a survey study. Can J Hosp Pharm. 2018;71(2):105–10. PubMed DOI PMC
International Pharmaceutical Federation (FIP). FIP strategic plan 2019–24. https://www.fip.org/files/content/about/vision-mission/FIP-strategic-plan-2019-2024.pdf . Accessed 14 Feb 2025
Moura L, Steurbaut S, Salvesen Blix H, et al. A cross-sectional survey to map Clinical Pharmacy Education and Practice in Europe. Int J Clin Pharm. 2022;44(1):118–26. PubMed DOI
Saavedra-Mitjans M, Ferrand É, Garin N, et al. Role and impact of pharmacists in Spain: a scoping review. Int J Clin Pharm. 2018;40:1430–42. PubMed DOI
Bowsher G, Papamichail A, El Achi N, et al. A narrative review of health research capacity strengthening in low and middle-income countries: lessons for conflict-affected areas. Global Health. 2019;15(1):23. PubMed DOI PMC
Dawoud D, Chen AMH, Rossing CV, et al. Pharmacy practice research priorities during the COVID-19 pandemic: recommendations of a panel of experts convened by FIP Pharmacy Practice Research Special Interest Group. Res Social Adm Pharm. 2021;17(1):1903–7. PubMed DOI
American College of Clinical Pharmacy (ACCP). 2024–2026 Strategic Plan. Empowering the Pharmacy Academy and Pharmacists to Impact the Health Care Landscape. https://www.aacp.org/sites/default/files/2024-12/StrategicPlan-2024-2026.pdf . Accessed 22 Mar 2025
Obaid D, El-Dahiyat F, Babar ZU. Recommendations to improve pharmacy practice research in the Middle Eastern Arab countries. J Pharm Policy Pract. 2021;14(1):68. PubMed DOI PMC
European Society of Clinical Pharmacy. Webinars. https://escpweb.org/what-we-do/webinars/ . Accessed 19 Jan 2025.
Weidmann AE. Artificial intelligence in academic writing and clinical pharmacy education: consequences and opportunities. Int J Clin Pharm. 2024;46(3):751–4. PubMed DOI PMC
Sawyers L, Anderson C, Boyd MJ, et al. Astropharmacy: pushing the boundaries of the pharmacists’ role for sustainable space exploration. Res Social Adm Pharm. 2022;18(9):3612–21. PubMed DOI
Aziz S, Raza MA, Noreen M, et al. Astropharmacy: roles of pharmacist in space. Innov Pharm. 2022;13(3):4956. https://doi.org/10.24926/iip.v13i3.4956 . DOI
Wu MJ, Zhao K, Fils-Aime F. Response rates of online surveys in published research: a meta-analysis. Comput Hum Behav Rep. 2022;7:100206. DOI
Crocker JC, Ricci-Cabello I, Parker A, et al. Impact of patient and public involvement on enrolment and retention in clinical trials: systematic review and meta-analysis. BMJ. 2018;363:k4738. PubMed DOI PMC
Weidmann AE, Cadogan CA, Fialová D, et al. How to write a successful grant application: guidance provided by the European Society of Clinical Pharmacy. Int J Clin Pharm. 2023;45(3):781–6. PubMed DOI PMC
Wirth F, Cadogan CA, Fialová D, et al. Writing a manuscript for publication in a peer-reviewed scientific journal: guidance from the European Society of Clinical Pharmacy. Int J Clin Pharm. 2024;46(2):548–54. PubMed DOI PMC
Paudyal V, Okuyan B, Henman MC, et al. Scope, content and quality of clinical pharmacy practice guidelines: a systematic review. Int J Clin Pharm. 2024;46(1):56–69. PubMed DOI
